Life Sciences

A chat with AstraZeneca's head of real estate and asset strategies offers a glimpse into the company's global growth strategy and focus on quality workplaces.

A new global corporate entity in animal health makes its home in Maine.

A new R&D expansion at its home base in Wisconsin is just one expression of the company’s genetic predisposition to be both conscious and growth-oriented.

Recent reports on obesity, diabetes and lifelong exercise offer looming clouds of concern and a few bright rays of encouragement.

The medical distribution giant’s global HQ will leave the Bay Area for the DFW suburb of Irving.

Among other products, the company has made cannula in the Cornhusker State for 51 years. What’s a cannula, you ask?

Major projects will improve these institutions’ already sturdy constitutions.

Recreational cannabis just turned legal in Canada two days ago. Cannabis-related firms have been building facilities in Canada for years.

If drugs are the lifeblood of the life sciences, their abuse and misuse by the workforce is a health crisis.

Emeryville welcomes renewed investment from Spain’s Grifols in a legacy site.